Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026)
Shattuck Labs' (STTK) quarterly Amortizatization of Intangibles came in at $48000.0 in Q1 2026, up 2300.0% year-on-year from $2000.0 in Q1 2025, and down 83.22% on a QoQ basis from $286000.0 in Q4 2025.
Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 6 years of Amortizatization of Intangibles data on file, last reported at $48000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 2300.0% year-over-year to $48000.0 in Q1 2026; TTM through Mar 2026 was $499000.0, a 72.0% decrease from a year earlier, with the FY2025 full-year figure at $453000.0, down 78.94% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $48000.0, down from $286000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for STTK reached as high as $742000.0 in Q3 2024 and fell as low as -$981000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $162647.1 across 5 years, with a median of $213000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles slumped 20650.0% in 2022 and soared 2300.0% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $139000.0 in 2022, then soared by 207.91% to $428000.0 in 2023, then fell by 1.64% to $421000.0 in 2024, then tumbled by 32.07% to $286000.0 in 2025, then tumbled by 83.22% to $48000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $48000.0 in Q1 2026, $286000.0 in Q4 2025, and $166000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | 48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | 742,000.00 |
| Sep 30, 2024 | 742,000.00 |
| Jun 30, 2024 | 617,000.00 |
| Jun 30, 2024 | 617,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | 428,000.00 |
| Dec 31, 2023 | 428,000.00 |